Article Details
Retrieved on: 2021-03-31 21:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The use of an artificial intelligence-based platform to analyze forms is expected to save Food and Drug Administration reviewers of adverse drug ...
Article found on: gcn.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here